SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Immunoglobulin-like beta-sandwich (7299)
(-)
Superfamily: Immunoglobulin (5995)
(-)
Family: automated matches (864)
(-)
Protein domain: automated matches (864)
(-)
Human (Homo sapiens) [TaxId: 9606] (448)
1TZGL:1-106; M:1-106CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1U2HA:X-RAY STRUCTURE OF THE N-TERMINALLY TRUNCATED HUMAN APEP-1
1U6AL:1-107CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1WT5A:; B:THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528
1X9QA:14-124; A:153-2684M5.3 ANTI-FLUORESCEIN SINGLE CHAIN ANTIBODY FRAGMENT (SCFV)
1YA5A:1-100; A:101-198; B:1-100; B:101-197CRYSTAL STRUCTURE OF THE TITIN DOMAINS Z1Z2 IN COMPLEX WITH TELETHONIN
1ZA6A:1-113; C:1-113; E:1-113; G:1-113THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1ZLSL:2-107FAB 2G12 + MAN4
1ZLUK:2-107; L:2-107FAB 2G12 + MAN5
1ZLVK:2-107; L:2-107FAB 2G12 + MAN7
1ZLWK:2-107; L:2-107FAB 2G12 + MAN8
1ZT4C:184-281THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE
2A38A:1-100; A:101-194; B:1-100; B:101-194; C:1-100; C:101-194CRYSTAL STRUCTURE OF THE N-TERMINUS OF TITIN
2A9ML:; M:STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM
2AJ3A:2-107; C:2-107; E:2-107CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
2AXHA:3-115; A:116-244; B:3-115; B:116-244CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
2AXJA:3-115; A:116-244; B:3-115; B:116-244CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
2BNUA:2-115STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2CDFA:3-115; A:116-193; B:2-116; B:117-245STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
2CDGA:10-115; B:3-117; B:118-246STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2CMRL:1-106ACRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
2D3VA:3-94; A:95-195CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR A5 (LILRA5/LIR9/ILT11)
2D7TH:CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
2D9CA:SOLUTION STRUCTURE OF THE FIRST IG-LIKE DOMAIN OF SIGNAL-REGULATORY PROTEIN BETA-1 (SIRP-BETA-1)
2DL9A:SOLUTION STRUCTURE OF THE IG-LIKE DOMAIN OF HUMAN LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4
2DM2A:SOLUTION STRUCTURE OF THE FIRST IG DOMAIN OF HUMAN PALLADIN
2DM3A:SOLUTION STRUCTURE OF THE SECOND IG DOMAIN OF HUMAN PALLADIN
2EDFA:SOLUTION STRUCTURE OF THE SECOND IG-LIKE DOMAIN(2826-2915) FROM HUMAN OBSCURIN
2EDJA:SOLUTION STRUCTURE OF THE FIFTH IG-LIKE DOMAIN FROM HUMAN ROUNDABOUT HOMOLOG 2
2EDKA:SOLUTION STRUCTURE OF THE THIRD IG-LIKE DOMAIN FROM HUMAN MYOSIN-BINDING PROTEIN C, FAST-TYPE
2EDNA:SOLUTION STRUCTURE OF THE FIRST IG-LIKE DOMAIN FROM HUMAN MYOSIN-BINDING PROTEIN C, FAST-TYPE
2EIZB:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX
2EKSB:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX
2ENYA:SOLUTION STRUCTURE OF THE IG-LIKE DOMAIN (2735-2825) OF HUMAN OBSCURIN
2EO1A:SOLUTION STRUCTURE OF THE IG DOMAIN OF HUMAN OBSCN PROTEIN
2EYRA:1-117; B:3-119A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYSA:1-117; B:3-119A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYTA:1-117; B:3-119; C:1-117; D:3-119A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2F8VA:2-100; A:101-195; B:1-100; B:101-197; C:4-100; C:101-194; D:2-100; D:101-194STRUCTURE OF FULL LENGTH TELETHONIN IN COMPLEX WITH THE N-TERMINUS OF TITIN
2FJFA:1-107; C:1-107; E:1-107; G:1-107; J:1-107; L:1-107; M:1-107; O:1-107; Q:1-107; S:1-107; U:1-107; W:1-107STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB
2FJGA:1-107; L:1-107STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FJHA:1-106; L:1-106STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FL5A:1-106; A:107-212; C:1-106; C:107-212; E:1-106; E:107-212; L:1-106; L:107-212COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2GI7A:2-88; A:89-183; B:0-88; B:89-183CRYSTAL STRUCTURE OF HUMAN PLATELET GLYCOPROTEIN VI (GPVI)
2GW5A:3-97CRYSTAL STRUCTURE OF LIR-2 (ILT4) AT 1.8 : DIFFERENCES FROM LIR-1 (ILT2) IN REGIONS IMPLICATED IN THE BINDING OF THE CYTOMEGALOVIRUS CLASS I MHC HOMOLOG UL18
2H32A:CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
2H9GA:1-107; L:1-107CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
2HFFA:2-106A; L:1-106ACRYSTAL STRUCTURE OF CB2 FAB
2HFGL:1-106ACRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2IALA:1-109; B:2-112; C:1-109; D:2-112STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAMC:1-109; D:2-112STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAND:1-109; E:3-112; I:1-109; J:2-112; N:1-109; O:3-112; S:1-109; T:3-112STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2J6EM:1-108CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2JB5L:3-112FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1
2JB6A:3-112; L:4-112FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2
2JJSA:; B:STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2JJTA:; B:STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2JJUA:; B:STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA
2JJVA:; B:STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA(2)
2JJWA:STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) GAMMA
2KDGA:SOLUTION STRUCTURE OF THE 1ST IG DOMAIN OF MYOTILIN
2KKQA:SOLUTION NMR STRUCTURE OF THE IG-LIKE C2-TYPE 2 DOMAIN OF HUMAN MYOTILIN. NORTHEAST STRUCTURAL GENOMICS TARGET HR3158.
2NMSA:THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE INHIBITOR RECEPTOR EXPRESSED ON MYELOID CELLS IREM-1
2NTSP:3-118CRYSTAL STRUCTURE OF SEK-HVB5.1
2NW2A:1-117; B:1-118; B:119-247CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2NYYC:1-111CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2OLDA:1-112; B:1-112BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(2)21 CRYSTAL FORM
2OM5A:4-99; A:100-204; A:205-295; A:296-384N-TERMINAL FRAGMENT OF HUMAN TAX1
2OMBA:1-112; B:1-112; C:1-112; D:1-112BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM
2OMNA:1-112; B:1-112BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P4(3)2(1)2 CRYSTAL FORM
2OTPA:3-95; B:3-95CRYSTAL STRUCTURE OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 1 (ILT1/LIR7/LILRA2)
2OZ4A:283-366; A:186-282; A:367-450STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2PYFA:1-115CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
2Q87A:; B:; C:THE CRYSTAL STRUCTURE OF THE HUMAN IRP60 ECTODOMAIN
2QQKL:1-107NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQLL:1-106NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQNL:1-107NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
2R56L:1-107; M:1-107CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
2UV3A:; B:STRUCTURE OF THE SIGNAL-REGULATORY PROTEIN (SIRP) ALPHA DOMAIN THAT BINDS CD47.
2V9TA:COMPLEX BETWEEN THE SECOND LRR DOMAIN OF SLIT2 AND THE FIRST IG DOMAIN FROM ROBO1
2VLMD:3-112; E:5-115; E:116-244THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VXQL:1-107CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2VXSL:1-108; M:1-108; N:1-108; O:2-108STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY
2VXVL:1-107CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2WBJA:82-180; C:8-113; E:82-180; G:10-113TCR COMPLEX
2WP3T:CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG COMPLEX
2WQRA:228-330; A:331-438; A:439-545; B:225-330; B:331-438; B:439-546THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC
2WUBL:1-107; Q:1-107CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP
2WUCL:1-107CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
2WWKT:CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG F17R MUTANT COMPLEX
2WWMD:; T:CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG COMPLEX IN SPACE GROUP P1
2XA8L:1-111CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2XNAA:2-111; B:3-115; B:116-243CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
2XQBL:5-107CRYSTAL STRUCTURE OF ANTI-IL-15 ANTIBODY IN COMPLEX WITH HUMAN IL-15
2XTJD:THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB
2XWTB:2-107CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
2XY1A:207-300; A:301-398CRYSTAL STRUCTURE OF NCAM2 IG3-4
2XY2A:19-113; A:114-207CRYSTAL STRUCTURE OF NCAM2 IG1-2
2XZAL:1-109CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2XZCL:1-109CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2Y9RT:CRYSTAL STRUCTURE OF THE M10 DOMAIN OF TITIN
2YBRB:; E:; H:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YC1B:; E:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YD3A:29-123; A:124-228CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA
2YD5A:30-124; A:125-228CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR
2YD8A:30-124; A:125-227CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR IN COMPLEX WITH SUCROSE OCTASULPHATE
2YK1L:4-107STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE
2YKLL:4-107STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE
2YR3A:SOLUTION STRUCTURE OF THE FOURTH IG-LIKE DOMAIN FROM MYOSIN LIGHT CHAIN KINASE, SMOOTH MUSCLE
2YSSB:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HQ39KW47Y)-HEN LYSOZYME COMPLEX
2YUVA:SOLUTION STRUCTURE OF 2ND IMMUNOGLOBULIN DOMAIN OF SLOW TYPE MYOSIN-BINDING PROTEIN C
2YXMA:CRYSTAL STRUCTURE OF I-SET DOMAIN OF HUMAN MYOSIN BINDING PROTEINC
2ZNWA:1-106; A:124-236; B:1-106; B:124-236CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
2ZNXA:1-106; A:124-236; B:1-106; B:124-2365-FLUOROTRYPTOPHAN INCORPORATED SCFV10 COMPLEXED TO HEN EGG LYSOZYME
3AAZB:1-112; B:113-229; L:1-112; L:113-228CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3AUVA:12-117; A:135-253; B:11-117; B:135-252; C:11-117; C:135-252; D:11-118; D:135-253; E:11-117; E:135-252; F:11-117; F:136-252PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
3B2UD:1-107; D:108-213; G:1-107; G:108-213; K:1-107; K:108-213; L:1-107; L:108-213; O:1-107; O:108-213; R:1-107; R:108-213; U:1-107; U:108-213; X:1-107; X:108-213CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3BDYL:1-107DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3BE1L:1-107DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3BJ91:CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
3BN3B:1-87; B:88-196CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN
3BN9C:1-107; E:1-107CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
3BW9A:182-276CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12-MER PEPTIDE FROM THE PP65 PROTEIN
3BWAA:182-276CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8-MER PEPTIDE FROM THE PP65 PROTEIN
3C08L:4-106CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)
3D85A:1-107CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3DGGA:1-110; C:1-110CRYSTAL STRUCTURE OF FABOX108
3DIFA:1-107; C:1-107CRYSTAL STRUCTURE OF FABOX117
3DX9B:2-129; D:2-129CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3EO9L:1-107CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB
3EOAA:1-107; L:1-107CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM I
3EYOA:1-108; C:1-108CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3FN0L:3-107; L:108-211CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB Z13E1 IN COMPLEX WITH A 12-RESIDUE PEPTIDE CONTAINING THE Z13E1 EPITOPE ON GP41
3FZUD:1-107; L:1-107IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3G04A:1-107; A:108-208CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID-STIMULATING AUTOANTIBODY
3G6AA:1-108; L:1-108CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
3G6JE:1-106; G:1-106C3B IN COMPLEX WITH A C3B SPECIFIC FAB
3GBML:3-105; M:3-106ACRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
3GBNL:3-106ACRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ
3GIZL:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB
3GJEA:1-110; L:1-110RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3GKWL:1-107CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3GRWA:150-247; A:248-355; L:1-107FGFR3 IN COMPLEX WITH A FAB
3GSNA:2-111CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3H0TA:1-111HEPCIDIN-FAB COMPLEX
3H3PH:; I:; L:; M:CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
3HC0B:1-107; L:1-107BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
3HC3L:1-107BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HC4L:1-107BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HI1A:1-107; L:1-107STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING-SITE ANTIBODY F105
3HI5L:1-106CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57
3HI6L:2-106; Y:2-106CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
3HMWL:1-106CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3HMXL:1-106CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
3HUJE:1-117; F:2-118; G:1-117; H:1-118CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3IDXL:1-107CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222
3INUL:1-107; N:1-107CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
3JUYA:1-125; A:143-249; B:1-125; B:143-250; C:1-125; C:143-250; D:1-125; D:143-249; E:1-125; E:143-249; F:1-125; F:143-249CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3JWDL:1-107; O:1-107STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3K2UL:1-107CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
3KDMA:3-111; A:112-218; L:3-111; L:112-218CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE
3KNBA:CRYSTAL STRUCTURE OF THE TITIN C-TERMINUS IN COMPLEX WITH OBSCURIN-LIKE 1
3KR3L:1-108CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
3KVQA:CRYSTAL STRUCTURE OF VEGFR2 EXTRACELLULAR DOMAIN D7
3KYMA:1-107; C:1-107; E:1-107; G:1-107; I:1-107; K:1-107; M:1-107; O:1-107CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
3L5XL:1-107CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB
3L7FA:1-107; D:1-107; L:1-107STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836
3LH2H:; I:; J:; K:; L:; M:; N:; O:CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
3LHPH:; I:; L:; M:CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
3LMJL:1-112STRUCTURE OF HUMAN ANTI HIV 21C FAB
3LRSB:3-107; D:3-107; F:3-107; L:3-107STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3LZFL:2-107CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3M8OH:1-118; H:119-221; L:1-112HUMAN IGA1 FAB FRAGMENT
3MA9L:2-109; L:110-210CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066
3MACL:2-109; L:110-211CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
3MFFA:11-121; B:2-115; C:11-121; D:2-1151F1E8HU TCR
3MFGB:CRYSTAL STRUCTURE OF TOXIC SHOCK SYNDROME TOXIN 1 (TSST-1) IN COMPLEX WITH THE HUMAN T CELL RECEPTOR BETA CHAIN VBETA2.1 (EP-8)
3MLRL:1-111CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
3MLSL:1-111; M:1-111; N:1-111; O:1-111CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV-1 GP120 V3 MIMOTOPE
3MLTA:1-111; D:1-111; G:1-111; L:1-111CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3MLUL:2-112CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
3MLVL:2-112; M:1-112CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
3MLXL:2-108; M:2-108CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
3MLYL:1-107; M:1-107CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3MLZL:1-107CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
3MUGA:2-107; C:2-107; E:3-107; G:2-107; I:1-107; K:3-107CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3MUHL:2-107CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
3MXWL:1-107CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
3N9GL:1-111CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI-WEST NILE VIRUS MAB CR4354
3NA9L:1-107CRYSTAL STRUCTURE OF FAB15
3NAAL:1-107CRYSTAL STRUCTURE OF FAB15 MUT5
3NABL:1-107CRYSTAL STRUCTURE OF FAB15 MUT6
3NACL:1-107CRYSTAL STRUCTURE OF FAB15 MUT7
3NCJL:1-107CRYSTAL STRUCTURE OF FAB15 MUT8
3NFPB:1-106; L:1-106CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3NFSL:1-106CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
3NGBC:1-107; C:108-216; F:3-107; F:108-216; K:1-107; K:108-216; L:3-107; L:108-216CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
3NH7L:2-109; L:110-211; M:2-109; M:110-211; N:2-109; N:110-211; O:2-109; O:110-211CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA
3NPSC:3-106ACRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3NTCL:1-107; L:108-213CRYSTAL STRUCTURE OF KD-247 FAB, AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
3NZHL:1-107CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
3O4LD:7-111; E:2-117; E:118-246GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3O6FC:1-110; D:1-115; G:1-110; H:1-115CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3OAYK:1-107; L:1-107A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OAZK:1-107; L:1-107A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OB0K:1-107; L:1-107A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OF6A:2-119; B:2-119; C:1-119HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3OJ2C:251-359; D:251-359CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
3OJMB:251-361CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING P253R APERT MUTATION
3OJVC:147-249; C:250-359; D:147-249; D:250-359CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC'-BETAE LOOP
3OMZA:11-116; C:139-250; E:13-116; A:139-250; C:11-116CRYSTAL STRUCTURE OF MICA-SPECIFIC HUMAN GAMMA DELTA T CELL RECEPTOR
3OV6A:1000-1093; A:185-280CD1C IN COMPLEX WITH MPM (MANNOSYL-BETA1-PHOSPHOMYCOKETIDE)
3P0VL:1-107; M:1-107ANTI-EGFR/HER3 FAB DL11 ALONE
3P0YL:1-107ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
3P2TA:2-96; A:97-195CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR LILRB4 (ILT3/LIR-5/CD85K)
3PGFL:1-107CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3PL6A:82-180; C:2-113STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
3PUCA:ATOMIC RESOLUTION STRUCTURE OF TITIN DOMAIN M7
3PWPE:1-117THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3Q1SL:3-107; L:108-211HIV-1 NEUTRALIZING ANTIBODY Z13E1 IN COMPLEX WITH EPITOPE DISPLAY PROTEIN
3Q5OA:; B:CRYSTAL STRUCTURE OF HUMAN TITIN DOMAIN M10
3QCTL:108-213CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
3QCUL:108-213; M:108-213CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
3QCVL:108-213; M:108-213CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
3QDGE:4-117THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJE:4-117THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMD:2-109; E:2-115THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEHB:1-106; D:1-106; F:1-106; H:2-106CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEQD:2-109; E:1-114; E:115-243THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QEUB:4-117; E:3-117THE CRYSTAL STRUCTURE OF TCR DMF5
3QFJE:1-117THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3QH3B:1-116; D:1-116THE CRYSTAL STRUCTURE OF TCR A6
3QHFL:1-107CRYSTAL STRUCTURE OF FAB DEL2D1, A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
3QHZL:2-107; M:4-107CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
3QIBC:2-111CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QNXA:1-112; B:3-118; B:119-221ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QNYA:2-112; B:3-118; B:119-221; C:1-112; D:4-118; D:119-221MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QO1A:1-112MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
3QOS  [entry was replaced by entry 5I1D without any SCOP domain information]
3QOT  [entry was replaced by entry 5I18 without any SCOP domain information]
3QPQC:1-107; E:1-107; I:1-107; L:1-107CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3QPXL:1-106CRYSTAL STRUCTURE OF FAB C2507
3QQ9C:1-111; L:1-111CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3QRGL:1-111CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
3R1GL:1-107STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY
3REVA:3-117CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3RPIB:3-96; L:3-96CRYSTAL STRUCTURE OF FAB FROM 3BNC60, HIGHLY POTENT ANTI-HIV ANTIBODY
3S6CA:1001-1093; A:177-277STRUCTURE OF HUMAN CD1E
3S97C:133-237; D:133-237; D:238-329PTPRZ CNTN1 COMPLEX
3SDXA:184-280; C:184-277; E:1-114; F:2-118; F:119-247; G:1-114; H:1-118; H:119-247CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SE8L:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
3SE9L:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG04 IN COMPLEX WITH HIV-1 GP120
3SKJL:1-107; M:1-107STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
3SKNA:2-124; B:3-126; C:2-124; D:3-126; E:2-124; F:3-126; G:2-124; H:3-126CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3SM5  [entry was replaced by entry 5UGY without any SCOP domain information]
3SOBL:1-107; L:108-213THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
3SQOL:2-107; L:108-214PCSK9 J16 FAB COMPLEX
3T0VA:UNLIGANDED FLUOROGEN ACTIVATING PROTEIN M8VL
3T0WA:; B:FLUOROGEN ACTIVATING PROTEIN M8VL IN COMPLEX WITH DIMETHYLINDOLE RED
3T0XA:; B:FLUOROGEN ACTIVATING PROTEIN M8VLA4(S55P) IN COMPLEX WITH DIMETHYLINDOLE RED
3T2NL:1-108; M:1-108HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3TCLB:1-107; L:1-107CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
3THML:1-111CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01
3TJEL:1-111CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09
3TNMB:4-107; L:4-107CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
3TNNB:4-108; D:4-108; F:4-108; L:4-108CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
3TO4C:1-117; D:3-121STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3TV3L:3-107CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9
3TWCL:3-107CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
3TZVA:1-114; B:2-118; B:119-246; C:184-278; G:1-114; H:2-118; H:119-246CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D-LYSOPHOSPHATIDYLCHOLINE
3U1SL:2-107; L:108-213CRYSTAL STRUCTURE OF HUMAN FAB PGT145, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3U2SB:2-107; L:2-107CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
3U30B:1-107; E:1-107CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3U46B:1-107; L:1-107CH04H/CH02L P212121
3U4BL:1-107CH04H/CH02L FAB P4
3U4EB:2-107; L:1-107CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
3U6RA:; B:; H:; L:THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 SINGLE CHAIN FV FRAGMENT 1:7
3U7WL:1-105; L:106-214CRYSTAL STRUCTURE OF NIH45-46 FAB
3U7YL:3-101; L:102-210STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV
3UTPD:2-112; E:1-117; K:2-112; L:1-1171E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
3UX9B:4-111; B:136-254; D:4-111; D:136-255STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS
3VWJA:184-278; C:1-117; D:3-118; D:119-246TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
3VWKC:2-117; D:3-118TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX
3VXQA:1-113; B:2-114; B:115-243; D:1-113; E:2-114; E:115-243H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
3VXTA:2-111; B:1-112; B:113-241; C:2-111; D:1-112; D:113-241T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3W9DB:1-107; D:1-107STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
3W9EB:1-107STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD
3WD5L:1-106CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
3WJJA:233-341; A:342-444; B:238-341; B:342-443CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB
3WJLA:232-341; A:342-443; B:237-341; B:342-444CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB
3ZL4L:3-110ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA - LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
3ZTNL:1-106STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ.
4ACPA:238-341; A:342-444; B:237-341; B:342-444DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT
4AENA:84-180HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
4AH2A:84-180HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN CANONICAL ORIENTATION
4AIZA:; B:; C:; D:CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3
4AL8L:1-107STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4BM7A:237-341; A:342-443; B:238-341; B:342-445CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION
4BSVA:236-341; A:342-445; B:236-341; B:342-445HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1
4BSWA:236-341; A:342-445; B:236-341; B:342-445HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2
4BYHA:238-341; A:342-444; B:236-341; B:342-444CRYSTAL STRUCTURE OF SIALYLATED IGG FC
4CMMA:STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA V1
4D9LL:1-108; M:1-108; N:1-108; O:1-108FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
4D9QD:1-107; L:1-107INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4D9RD:1-107; L:1-107INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4DEPB:7-104; B:105-207; B:208-310; E:6-104; E:105-207; E:208-314STRUCTURE OF THE IL-1B SIGNALING COMPLEX
4DKFL:1-106; M:1-106CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
4DQOL:1-107CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4DTGL:1-111HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
4DZBA:1-110; B:2-117MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR, VALPHA7.2JALPHA33-VBETA2
4E41D:1-110; E:1-110; I:1-110; J:1-110STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4E42A:1-110; B:2-110; C:1-110; D:2-110STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4EDWL:1-107NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
4EN3A:8-113; B:2-117CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
4EOWL:2-111CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
4ERSL:1-106A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR
4EVNB:3-112; D:3-112; F:3-112; H:3-112; J:3-112; L:3-112; N:3-112; P:3-112CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE-REVERTED LIGHT CHAIN)
4EZMA:335-436; A:437-545; B:336-436; B:437-545; C:336-436; C:437-545; D:335-436; D:437-541; E:335-436; E:437-540; F:335-436; F:437-542CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23
4F57L:1-108FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4F58L:1-108; M:1-108; N:1-108; O:1-108FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4FNLL:1-106; M:1-106CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4FP8L:1-106; M:1-106; N:1-106; O:1-106CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT
4FQ1L:9-108; L:109-209CRYSTAL STRUCTURE OF PGT121 FAB
4FQ2L:8-108CRYSTAL STRUCTURE OF 10-1074 FAB
4FQCL:10-108; L:109-209CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N-GLYCAN
4FQHB:2-107; L:2-107CRYSTAL STRUCTURE OF FAB CR9114
4FQIL:2-107CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
4FQJL:1-107INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
4FQXA:82-181CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
4FZ8L:1-107CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4FZEL:2-107CRYSTAL STRUCTURE OF N26_I1 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4G3YL:1-107CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
4G7VL:1-107CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A)
4G7YL:1-107CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A)
4G8EA:1-127; B:3-134CRYSTAL STRUCTURE OF CLONE18 TCR
4G8FA:3-128; B:1-127CRYSTAL STRUCTURE OF CLONE42 TCR
4GRLC:2-113CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
4GRMB:3-117; D:1-117THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4GSDL:5-108H5.3 FAB STRUCTURE
4GW4B:4-96; L:4-96CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION
4GXVL:1-107; M:1-107CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
4H8WL:3-108CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
4HAFA:236-341; A:342-444; B:239-341; B:342-444CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)
4HBQA:1-90; B:1-90CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2
4HC1A:9-90; B:9-90CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
4HCRA:1-90; B:1-90; L:1-111; N:1-111CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
4HD9A:1-90CRYSTAL STRUCTURE OF NATIVE HUMAN MADCAM-1 D1D2 DOMAIN
4HF5L:3-107CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFUL:1-106CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFWA:2-106; L:1-106ANTI ROTAVIRUS ANTIBODY
4HH9A:1-107; C:1-107ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
4HIEA:2-107; A:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102
4HIHA:2-107; A:108-211; C:2-107; C:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
4HIIA:2-107; A:108-211; C:2-107; C:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE-GALACTOSE
4HIJA:5-107; A:108-211; C:2-107; C:108-211ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE-(1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
4HJGA:1-107MEDITOPE-ENABLED TRASTUZUMAB
4HJJL:1-113; L:114-228; L:229-327STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
4HK0B:1-109; D:1-109UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HK3N:1-109I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HKXB:1-109INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB
4HKZA:1-107TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
4HQQL:1-107CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
4HWBL:1-104; L:105-212CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4I2XA:1-107; C:1-107CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
4I3RL:1-106CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
4I3SL:1-107CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
4I77L:1-107LEBRIKIZUMAB FAB BOUND TO IL-13
4IIQA:2-110; B:2-116CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
4IMKC:3-109; C:110-215; D:3-109; D:110-212UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2
4IOIA:1-107MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
4J4PD:19-130; L:19-130THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
4J6RL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120
4JAMB:3-107; L:2-107CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
4JANB:2-105; L:2-105CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4JB9L:1-102CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE
4JFHE:1-116HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
4JFXA:1-107; L:1-107STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
4JFYA:1-107; L:1-107APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
4JFZL:1-107STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG0L:1-107STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG1L:1-107STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE
4JHAL:1-107CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
4JKPL:3-101; L:102-209RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI-HIV-1 ANTIBODIES
4JKWA:STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH ISOPENTENYL PYROPHOSPHATE (IPP)
4JM2B:1-106CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4JM4L:1-107CRYSTAL STRUCTURE OF PGT 135 FAB
4JPIB:2-109; L:2-109CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPKL:1-109CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPVL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120
4JPWL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT
4JY4A:9-108; A:109-211CRYSTAL STRUCTURE OF HUMAN FAB PGT121, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4JY5L:8-108CRYSTAL STRUCTURE OF HUMAN FAB PGT122, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4JY6A:8-111; A:112-213; C:8-108; C:109-210CRYSTAL STRUCTURE OF HUMAN FAB PGT123, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4K55A:STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE (HMBPP)
4K7PX:1-107GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4K94L:3-108; L:109-212CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODY FAB19
4KHTL:2-109; L:110-210TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066
4KHXL:2-109; L:110-208CRYSTAL STRUCTURE OF GP41 HELIX COMPLEXED WITH ANTIBODY 8062
4KJYB:; D:COMPLEX OF HIGH-AFFINITY SIRP ALPHA VARIANT FD6 WITH CD47
4KMTL:1-107CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4KQ3L:1-106CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
4KU1A:237-341; A:342-443; B:237-341; B:342-444ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING
4KVNL:2-106CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)
4KY1L:1-107HUMANIZED HP1/2 FAB
4L4JA:237-341; A:342-444; B:239-341; B:342-444CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY
4L4TA:179-269; C:179-269; D:1-110; E:2-116; E:117-244; G:1-110; H:3-116; H:117-244STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
4L4VA:179-269; E:117-244; G:1-110; H:3-116; H:117-242; C:179-269; D:1-110; E:2-116STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
4L8SA:3-110; B:2-115; B:116-243CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
4LCWA:179-269; C:179-269; D:1-110; E:2-116; E:117-244; G:1-110; H:3-116; H:117-242THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4LFHD:5-120; D:121-206; G:10-125CRYSTAL STRUCTURE OF 9C2 TCR
4LHUA:184-277; D:5-120; D:121-206; G:10-125CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
4LKCA:2-108AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
4LL9A:2-100; A:101-197; B:2-100; B:101-197; C:2-100; C:101-197CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB1 MOLECULE
4LLAA:4-99; A:100-201; B:4-99; B:100-201; C:4-99; C:100-201CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
4LLDB:STRUCTURE OF WILD-TYPE IGG1 ANTIBODY HEAVY CHAIN CONSTANT DOMAIN 1 AND LIGHT CHAIN LAMBDA CONSTANT DOMAIN (IGG1 CH1:CLAMBDA) AT 1.19A
4LLUB:1-107; B:108-210; D:1-106; D:110-209STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
4LLVA:; B:; C:; D:; E:; F:; H:; L:THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV
4LMQI:1-107; L:1-107DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
4LSPL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
4LSQL:1-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN 3415_V1_C1
4LSSL:3-107; L:108-216CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120
4LSTL:1-107; L:108-216CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120
4LSUL:2-107CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4M1DL:1-106A; L:107-211; M:2-106A; M:107-209CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
4M5YL:1-106A; L:107-209; M:1-106A; M:107-209CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
4M5ZL:1-106A; L:107-210CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 5J8 BOUND TO 2009 PANDEMIC INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT
4M6ML:1-112CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
4M6OL:1-107CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
4MAYC:2-113CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
4MNGE:2-119; E:147-256; F:2-119; F:147-256STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
4MQ7A:184-278STRUCTURE OF HUMAN CD1D-SULFATIDE
4N0FA:177-267; E:177-267; H:177-267; K:177-267HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
4NDMA:9-118; B:1-121STRUCTURE OF THE AB18.1 TCR
4NM4L:1-107; M:1-107CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
4NPYA:1-106A; A:107-208; L:1-106A; L:107-209CRYSTAL STRUCTURE OF GERMLINE FAB PGT121, A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4NQTA:237-341; A:342-444ANTI-PARALLEL FC-HOLE(T366S/L368A/Y407V) HOMODIMER
4NQUA:237-341; A:342-444ANTI-PARALLEL FC-KNOB (T366W) HOMODIMER
4NRYB:1-107; B:108-211; L:1-107; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
4NRZB:1-107; L:1-107CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
4NZRL:1-107CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
4NZTL:2-107CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4NZUL:1-107CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT
4OAWC:1-107FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
4OCSL:3-107CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD1L:3-107CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD3L:2-107CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4PS4L:1-106CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB